[Federal Register Volume 69, Number 153 (Tuesday, August 10, 2004)]
[Notices]
[Page 48523]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-18173]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances, Notice of Registration

    By notice dated March 5, 2004, and published in the Federal 
Register on March 15, 2004 (69 FR 12179), Lin Zhi International, Inc., 
687 North Pastoria Avenue, Sunnyvale, California 94085, made 
application by renewal to the Drug Enforcement Administration (DEA) to 
be registered as a bulk manufacturer of eleven basic classes of 
controlled substances in Schedule I and II. On April 13, 2004, the firm 
submitted a latter to DEA which stated that only six of the basic 
classes of controlled substances were intended for bulk manufacture. 
The corrected list of drug codes is as follows:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Tetrahydrocannabinols (7370)...............  I
3,4-Methylenedioxymethamphetamine (7405)...  I
Cocaine (9041).............................  II
Methadone (9250)...........................  II
Dextropropoxyphene (9273)..................  II
Morphine (9300)............................  II
------------------------------------------------------------------------

    The company plans to manufacture small quantities of controlled 
substances to make drug testing reagents and controls.
    No comments or objection have been received. DEA has considered the 
factors in 21 U.S.C. 823(a) and determined that the registration of Lin 
Zhi International, Inc. to manufacture the listed basic classes of 
controlled substances is consistent with the public interest at this 
time. DEA has investigated Lin Zhi International, Inc. to ensure that 
the company's registration is consistent with the public interest. The 
investigation has included inspection and testing of the company's 
physical security systems, verification of the company's compliance 
with state and local laws, and a review of the company's background and 
history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 
21 CFR 1301.33, the above named company is granted registration as a 
bulk manufacturer of the basic classes of controlled substances listed.

    Dated: July 28, 2004.
Joseph T. Rannazzisi,
Deputy Director, Office of Diversion Control, Drug Enforcement 
Administration.
[FR Doc. 04-18173 Filed 8-9-04; 8:45 am]
BILLING CODE 4410-09-M